Antibodies to gangliosides and ganglioside complexes in Guillain–Barré syndrome and Fisher syndrome: Mini-review
- 30 June 2010
- journal article
- review article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 223 (1-2), 5-12
- https://doi.org/10.1016/j.jneuroim.2010.02.001
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Gangliosides in cell recognition and membrane protein regulationCurrent Opinion in Structural Biology, 2009
- Analysis of lectin binding to glycolipid complexes using combinatorial glycoarraysGlycobiology, 2009
- The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in miceJCI Insight, 2009
- Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A reviewGlycobiology, 2009
- Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathwayProceedings of the National Academy of Sciences of the United States of America, 2008
- Anti-ganglioside antibodies alter presynaptic release and calcium influxNeurobiology of Disease, 2007
- Anti-ganglioside complex antibodies in Miller Fisher syndromeJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Effects of phospholipids on antiganglioside antibody reactivity in GBSJournal of Neuroimmunology, 2005
- Differences in membrane properties of axonal and demyelinating Guillain‐Barré syndromesAnnals of Neurology, 2002
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 1996